Skip to main content
. 2020 Jun 18;12(6):1610. doi: 10.3390/cancers12061610

Figure 2.

Figure 2

Dose- and time-dependent effects of deptropine on the cell viability of human hepatoma cells. (a) Hep3B and (b) HepG2 cells were treated with different concentrations of deptropine for 24, 48, or 72 h, and cell viability was determined by an 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Data are presented as the mean ± standard error of three independent experiments.